ScholarIQanswers from OpenAlex & ORCID
Toshinari Yamasaki
ResearcherPublications, citations & collaboration network
Toshinari Yamasaki is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Toshinari Yamasaki have?
ScholarIQindexed works
Toshinari Yamasaki has 228 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Toshinari Yamasaki have?
ScholarIQcitation count
Toshinari Yamasaki has 3,524 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Toshinari Yamasaki?
ScholarIQh-index
Toshinari Yamasaki has an h-index of 28 in OpenAlex.
What is the i10-index of Toshinari Yamasaki?
ScholarIQi10-index
Toshinari Yamasaki has an i10-index of 56 in OpenAlex.
What is the OpenAlex record for Toshinari Yamasaki?
ScholarIQopenalex
The OpenAlex for Toshinari Yamasaki is on the source record.
What are the most-cited papers on Toshinari Yamasaki?
ScholarIQmost cited works
BAP1 loss defines a new class of renal cell carcinoma
Samuel Peña‐Llopis, Silvia Vega-Rubín-de-Celis, Arnold Liao, Nan Leng, Andrea Pavía-Jiménez, Shanshan Wang, Toshinari Yamasaki, Leah Zhrebker, Sharanya Sivanand, Patrick Spence, Lisa N. Kinch, Tina Hambuch, Suneer Jain, Yair Lotan, Vitaly Margulis, Arthur I. Sagalowsky, Pia Banerji Summerour, Wareef Kabbani, SL Wong, Nick V. Grishin, Marc Laurent, Xian-Jin Xie, Christian Haudenschild, Mark T. Ross, David Bentley, Payal Kapur, James Brugarolas
Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism
Youichi Ohno, Masakatsu Sone, Nobuya Inagaki, Toshinari Yamasaki, Osamu Ogawa, Yoshiyu Takeda, Isao Kurihara, Hiroshi Itoh, Hironobu Umakoshi, Mika Tsuiki, Takamasa Ichijo, Takuyuki Katabami, Yasushi Tanaka, Norio Wada, Yui Shibayama, Takanobu Yoshimoto, Yoshihiro Ogawa, Junji Kawashima, Katsutoshi Takahashi, Megumi Fujita, Minemori Watanabe, Yuichi Matsuda, Hiroki Kobayashi, Hirotaka Shibata, Kohei Kamemura, Michio Otsuki, Yuichi Fujii, Kōichi Yamamoto, Atsushi Ogo, Shintaro Okamura, Shozo Miyauchi, Tomikazu Fukuoka, Shoichiro Izawa, Takashi Yoneda, Shigeatsu Hashimoto, Toshihiko Yanase, Tomoko Suzuki, Takashi Kawamura, Yasuharu Tabara, Fumihiko Matsuda, Mitsuhide Naruse, Nagahama Study*, Takahisa Kawaguchi, Kazuya Setoh, Fumihiko Matsuda, Yoshimitsu Takahashi, Takeo Nakayama, Shinji Kosugi
A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
Sharanya Sivanand, Samuel Peña‐Llopis, Hong Zhao, Blanka Kucejová, Patrick Spence, Andrea Pavía-Jiménez, Toshinari Yamasaki, David J. McBride, J. Gillen, Nicholas C. Wolff, Lorraine Morlock, Yair Lotan, Ganesh V. Raj, Arthur I. Sagalowsky, Vitaly Margulis, Jeffrey A. Cadeddu, Mark T. Ross, David Bentley, Wareef Kabbani, Xian-Jin Xie, Payal Kapur, Noelle S. Williams, James Brugarolas
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab
Ichiro Yamauchi, Akihiro Yasoda, Shigemi Matsumoto, Yuichi Sakamori, Young Hak Kim, Motoo Nomura, Atsushi Otsuka, Toshinari Yamasaki, Ryoichi Saito, Morimasa Kitamura, Toshio Kitawaki, Masakatsu Hishizawa, Nobuko Kawaguchi‐Sakita, Toshihito Fujii, Daisuke Taura, Masakatsu Sone, Nobuya Inagaki
Interplay Between pVHL and mTORC1 Pathways in Clear-Cell Renal Cell Carcinoma
Blanka Kucejová, Samuel Peña‐Llopis, Toshinari Yamasaki, Sharanya Sivanand, Tram Anh T. Tran, Shane Alexander, Nicholas C. Wolff, Yair Lotan, Xian-Jin Xie, Wareef Kabbani, Payal Kapur, James Brugarolas